期刊文献+

激素替代治疗围绝经期综合征的临床观察 被引量:30

Clinical Observation of Hormone Replacement Therapy in Perimenopausal Syndrome
下载PDF
导出
摘要 目的:探讨激素替代治疗围绝经期综合征的临床疗效和安全性。方法:80例患者采用随机数字的方法分为观察组和对照组各40例,观察组采用激素替代治疗,对照组采用谷维素治疗,比较二者临床疗效。结果:观察组患者Kupperman评分较对照组下降更明显(P<0.05);两组患者治疗后血清E2水平增加,FSH和LH水平下降,但是观察组患者变化幅度更明显(P<0.05);两组患者治疗后子宫内膜厚度均增加(P<0.05),但是观察组患者增加幅度更大(P<0.05)。结论:小剂量激素替代治疗围绝经期综合征安全有效,但临床治疗应把握好适应症和禁忌症。 Objective: To investigate the clinical efficacy and safety of hormone replacement therapy in perimenopausal syndrome.Method:80 cases of patients were randomly divided into the observation group and the control group(n=40 cases),the observation group was treated with hormone replacement therapy,while the control group used oryzanol tablets,compared the clinical efficacy.Result: The patients in the observation group Kupperman score than the control group decreased more obviously(P 0.05);two groups of patients after treatment of the level of serum E2 increased,FSH and LH level decreased,but the observation group were more obvious changes in amplitude(P 0.05);both of two groups after treatment of endometrial thickness were increased(P 0.05),but the observation group was increased greatly(P 0.05).Conclusion: low dose hormone replacement therapy in perimenopausal syndrome is safe and effective,but the clinical treatment should be good grasp of the indications and contraindications.
作者 陈玉仙
出处 《河北医学》 CAS 2012年第10期1384-1387,共4页 Hebei Medicine
关键词 围绝经期综合征 激素替代治疗 谷维素 安全性 Perimenopausal syndrome Hormone replacement therapy Oryzanol Safety
  • 相关文献

参考文献4

二级参考文献13

共引文献24

同被引文献200

引证文献30

二级引证文献226

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部